Hologic Inc.
Hologic Inc (HOLX) is a US-based medical technology company best known for diagnostic products and surgical devices with a strong emphasis on women’s health. Its revenue mix includes molecular diagnostics, breast and skeletal health imaging, and specialised surgical systems. The business benefits from recurring consumables revenue, installed equipment bases and frequent new-product introductions, but it also faces competition, pricing pressure in certain markets and regulatory oversight from agencies such as the FDA. Recent years saw demand swings tied to pandemic testing, which have normalised, so future growth will depend more on core diagnostic adoption, product innovation and potential bolt-on acquisitions. Investors should watch margins, R&D spending, and the company’s ability to convert new approvals into sustained sales. As with any equity, performance can vary and past moves are not a reliable guide to the future; this is general educational information and not personalised investment advice.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Hologic's stock with a target price of $74.54, indicating limited upside.
Financial Health
Hologic Inc. is performing well with strong revenue and cash flow, indicating solid financial stability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring HOLX
Healthcare's Efficiency Imperative
UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.
Published: July 30, 2025
Explore BasketDiagnostic Takeover Targets
This carefully selected group of stocks features innovative diagnostic companies that could become acquisition targets following recent takeover interest in the sector. Professional analysts have identified these companies for their unique technologies and established market positions in a consolidating healthcare landscape.
Published: July 15, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Diagnostics Momentum
Molecular and lab diagnostics drive recurring revenue via tests and consumables, though demand can fluctuate and past pandemic tailwinds have faded.
Women’s Health Focus
A concentrated product set around women’s health creates niche leadership potential, but also means exposure to sector-specific reimbursement and regulatory shifts.
Innovation & M&A
Regular R&D and targeted acquisitions can expand the addressable market, yet integration and execution risk remain important to monitor.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
